A Randomized Study Comparing Sitagliptin In Combination With Metformin Versus Metformin Alone To Prevent Weight Regain In Obese Women With Polycystic Ovary Syndrome (PCOS) Previously Treated With Liraglutide

Trial Profile

A Randomized Study Comparing Sitagliptin In Combination With Metformin Versus Metformin Alone To Prevent Weight Regain In Obese Women With Polycystic Ovary Syndrome (PCOS) Previously Treated With Liraglutide

Completed
Phase of Trial: Phase II

Latest Information Update: 20 Apr 2017

At a glance

  • Drugs Metformin (Primary) ; Sitagliptin (Primary)
  • Indications Obesity; Weight gain
  • Focus Therapeutic Use
  • Most Recent Events

    • 20 Apr 2017 New trial record
    • 04 Apr 2017 Primary endpoint has been met for anthropometric measures of obesity i.e weight change, percentage of weight change and BMI change, according to results presented at The 99th Annual Meeting of the Endocrine Society.
    • 04 Apr 2017 Results presented at The 99th Annual Meeting of the Endocrine Society.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top